Cart
sales@molnova.com
SXC 2023
CAS No. 1695562-36-7
SXC 2023( —— )
Catalog No. M36974 CAS No. 1695562-36-7
SXC 2023 ((S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid) is a therapeutic prodrug of N-acetyl-L-cysteine for the treatment of CNS disorders and neurocognitive disorders, and can be used to treat glutamatergic dysfunction and psychiatric disorders in which oxidative stress plays a key role.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 33 | In Stock |
|
| 10MG | 53 | In Stock |
|
| 25MG | 89 | In Stock |
|
| 50MG | 140 | In Stock |
|
| 100MG | 212 | In Stock |
|
| 200MG | 318 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSXC 2023
-
NoteResearch use only, not for human use.
-
Brief DescriptionSXC 2023 ((S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid) is a therapeutic prodrug of N-acetyl-L-cysteine for the treatment of CNS disorders and neurocognitive disorders, and can be used to treat glutamatergic dysfunction and psychiatric disorders in which oxidative stress plays a key role.
-
DescriptionSXC 2023 ((S)-2-acetamido-3-(4-methylbenzoylthio)propanoic acid) is a therapeutic prodrug of N-acetyl-L-cysteine for the treatment of CNS disorders and neurocognitive disorders, and can be used to treat glutamatergic dysfunction and psychiatric disorders in which oxidative stress plays a key role.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1695562-36-7
-
Formula Weight281.33
-
Molecular FormulaC13H15NO4S
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESC(SC[C@H](NC(C)=O)C(O)=O)(=O)C1=CC=C(C)C=C1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
NS-2028
NS-2028 is a highly selective soluble Guanylyl Cyclase (sGC) inhibitor (IC50: 30 nM and 200 nM for basal and NO-stimulated enzyme activity).
-
CL2A-SN-38 DCA 127...
CL2A-SN-38 is a drug-linker conjugate composed of a potent a DNA Topoisomerase I inhibitor SN-38 and a linker CL2A to make antibody drug conjugate (ADC).
-
Isoflurane
Isoflurane is a stable, non-explosive inhalation anesthetic that has been reported to induce caspase-3 activation.
